Connection

Jesús Porta-Etessam to Immunosuppressive Agents

This is a "connection" page, showing publications Jesús Porta-Etessam has written about Immunosuppressive Agents.
  1. Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal. J Med Virol. 2021 01; 93(1):546-549.
    View in: PubMed
    Score: 0.057
  2. Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab. Mult Scler Relat Disord. 2020 Sep; 44:102297.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.